Screen-printed electrode produced by printed-circuit board technology. Application to cancer biomarker detection by means of plastic antibody as sensing material

SENSORS AND ACTUATORS B-CHEMICAL

卷:223

Article

Moreira, Felismina T. C.¹  Ferreira, M. Judite M. S.²  Puga, Jose R. T.²  Sales, M. Goreti F.¹ 

[1] Polytech Inst Porto, Sch Engn, BioMark, CINTESIS,ISEP, Oporto, Portugal

[2] Polytech Inst Porto, Sch Engn, TID, CINTESIS, Oporto, Portugal

关键词: Screen printed electrodes;    Printed circuit board;    Molecular Imprinting;    Electropolymerization;    Carcinogenic embryonic antigen;    Biosensor;   

DOI  :  10.1016/j.snb.2015.09.157

来源: Elsevier

【 摘 要 】

This research work presents, for the first time, a screen-printed electrode (SPE) made on a PCB board with silver tracks (Ag) and a three electrode configuration (AgxO-working, AgxO-counter and Ag/AgxO-reference electrodes), following the same approach as printed-circuit boards (PCBs). This low cost and disposable device was tested for screening a cancer biomarker in point-of-care. The selected biomarker was carcinogenic embryonic antigen ( CEA) protein, routinely used to follow-up the progression of specific cancer diseases. The biosensor was constructed by assembling a plastic antibody on the Ag-working electrode area, acting as the biorecognition element of the device. The protein molecules that were entrapped on the polymer and positioned at the outer surface of the polypyrrole (PPy) film were removed by protease action. The imprinting effect was tested by preparing non-imprinted (NPPy) material, including only PPy as biorecognition element. Infrared and Raman studies confirmed the surface modification of these electrodes. The ability of the sensing material to rebind CEA was measured by several electrochemical techniques: cyclic voltammetry (CV), impedance spectroscopy (EIS) and square wave voltammetry (SWV). The linear response ranged from 0.05 to 1.25 pg/mL against logarithm concentration. Overall, producing screen-printed electrodes by means of conventional PCB technology showed promising features, mostly regarding cost and prompt availability. The plastic antibody-based biosensor also seems to be a promising tool for screening CEA in point-of-care, with low response time, low cost, good sensitivity and high stability. (C) 2015 The Authors. Published by Elsevier B.V.

【 授权许可】

Free